Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 10, 2021
Reporting Period: Second quarter ended June 30, 2021
Context: The filing serves to announce the Company's financial results for the second quarter of 2021. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. Consequently, the following metrics are not available in this document:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Note: Specific financial values must be sourced from the referenced Exhibit 99.1 (Press Release), which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes in financial condition or operations compared to the prior comparable period. It only confirms that results for the quarter ended June 30, 2021, were announced.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 10, 2021) for actual revenue, net loss, and cash position figures.
- Verify the Company's status as an Emerging Growth Company (indicated as checked in the filing) and its election regarding extended transition periods for accounting standards.
- Confirm the trading symbol IDYA on The Nasdaq Global Select Market.
- Check for any subsequent filings that may incorporate the furnished information by reference.